KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for AbbVie (ABBV) over the last 11 years, with Q3 2025 value amounting to $9.0 million.

  • AbbVie's Long-Term Debt Repayments fell 9776.67% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 billion, marking a year-over-year increase of 12233.84%. This contributed to the annual value of $9.6 billion for FY2024, which is 13169.44% up from last year.
  • Per AbbVie's latest filing, its Long-Term Debt Repayments stood at $9.0 million for Q3 2025, which was down 9776.67% from $3.8 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Long-Term Debt Repayments ranged from a high of $6.9 billion in Q4 2022 and a low of $2.0 million during Q2 2022
  • Over the past 5 years, AbbVie's median Long-Term Debt Repayments value was $2.5 billion (recorded in 2021), while the average stood at $2.5 billion.
  • Per our database at Business Quant, AbbVie's Long-Term Debt Repayments tumbled by 9994.22% in 2022 and then soared by 5000000.0% in 2023.
  • Quarter analysis of 5 years shows AbbVie's Long-Term Debt Repayments stood at $3.8 billion in 2021, then soared by 82.6% to $6.9 billion in 2022, then crashed by 73.81% to $1.8 billion in 2023, then surged by 221.18% to $5.8 billion in 2024, then tumbled by 99.84% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $3.8 billion for Q2 2025, and $3.0 billion during Q1 2025.